| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Kaufman DS | |
| Thomson JA | |||
| Odorico JS | |||
| P2860 | cites work | Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells | Q24616059 |
| Establishment in culture of pluripotential cells from mouse embryos | Q27860625 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro | Q29617383 | ||
| Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture | Q40843384 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 193-204 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Multilineage differentiation from human embryonic stem cell lines | |
| P478 | volume | 19 |
| Q38437079 | 3D culture of tonsil-derived mesenchymal stem cells in poly(ethylene glycol)-poly(L-alanine-co-L-phenyl alanine) thermogel. |
| Q33941252 | A DNMT3B alternatively spliced exon and encoded peptide are novel biomarkers of human pluripotent stem cells |
| Q92888130 | A Method of Three-Dimensional Micro-Rotational Flow Generation for Biological Applications |
| Q50074653 | A Non-apoptotic Function of MCL-1 in Promoting Pluripotency and Modulating Mitochondrial Dynamics in Stem Cells. |
| Q38758867 | A PDMS-Based Microfluidic Hanging Drop Chip for Embryoid Body Formation. |
| Q33730030 | A brief review of in vitro models of diabetic neuropathy |
| Q53770256 | A comprehensive approach to the molecular determinants of lifespan using a Boolean model of geroconversion. |
| Q35072907 | A glance into somatic stem cell biology: basic principles, new concepts, and clinical relevance |
| Q28749168 | A photoprotein in mouse embryonic stem cells measures Ca2+ mobilization in cells and in animals |
| Q35138057 | A porous membrane-mediated isolation of mesenchymal stem cells from human embryonic stem cells |
| Q35721444 | A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells |
| Q30436837 | A review of gene delivery and stem cell based therapies for regenerating inner ear hair cells |
| Q51335529 | A simple method for forming embryoid body from mouse embryonic stem cells. |
| Q37299126 | A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells. |
| Q26827706 | Actions of endocrine-disrupting chemicals on stem/progenitor cells during development and disease |
| Q36054934 | Acute liver failure: Summary of a workshop |
| Q36686008 | Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present strategies and future perspectives of therapies |
| Q35751726 | Adhesive forces in embryonic stem cell cultures |
| Q34106626 | Advances in reprogramming somatic cells to induced pluripotent stem cells |
| Q39278820 | Altered characteristics of cancer stem/initiating cells in a breast cancer cell line treated with persistent 5-FU chemotherapy |
| Q49388367 | Amniotic Fluid Stem Cells: A New Era in Regenerative Medicine |
| Q35769669 | Amniotic fluid stem cells provide considerable advantages in epidermal regeneration: B7H4 creates a moderate inflammation microenvironment to promote wound repair |
| Q35022831 | An in vitro mechanism study on the proliferation and pluripotency of human embryonic stems cells in response to magnesium degradation |
| Q55371120 | Angiogenic and osteogenic potentials of dental stem cells in bone tissue engineering. |
| Q36804663 | Applications of gene therapy and adult stem cells in bone bioengineering. |
| Q30373248 | Aspects on properties, use and ethical considerations of embryonic stem cells - A short review. |
| Q35758103 | Assessing self-renewal and differentiation in human embryonic stem cell lines |
| Q35189283 | Bio-engineering inslulin-secreting cells from embryonic stem cells: a review of progress |
| Q37202810 | Bioartificial liver systems: why, what, whither? |
| Q40323748 | Biocompatibility of poly-DL-lactic acid (PDLLA) for lung tissue engineering |
| Q33733340 | Bioinspired materials for controlling stem cell fate |
| Q27025631 | Biomaterials and stem cells for tissue engineering |
| Q34019315 | Biomineralized matrix-assisted osteogenic differentiation of human embryonic stem cells |
| Q36530003 | Bioreactors for extracorporeal liver support |
| Q37586295 | Blastocyst injection of embryonic stem cells: a simple approach to unveil mechanisms of corrections in mouse models of human disease |
| Q24615347 | Cardiac applications for human pluripotent stem cells |
| Q36349185 | Cardiac repair by embryonic stem-derived cells |
| Q36267790 | Cardiac stem cells and mechanisms of myocardial regeneration |
| Q35122190 | Cardiac stem/progenitor cells, secreted proteins, and proteomics |
| Q36672272 | Cardiovascular genomics: a current overview of in vivo and in vitro studies |
| Q37732186 | Cell-based therapeutic approaches for Parkinson's disease: progress and perspectives |
| Q28206557 | Cellular replacement therapy for Parkinson's disease--where we are today? |
| Q36377192 | Cellular therapies for kidney failure |
| Q50281825 | Cerebral organoids reveal early cortical maldevelopment in schizophrenia—computational anatomy and genomics, role of FGFR1. |
| Q41597167 | Chapter 17 Sterile Plate-Based Vitrification of Adherent Human Pluripotent Stem Cells and Their Derivatives Using the TWIST Method |
| Q33828823 | Characterisation of human embryonic stem cells conditioning media by 1H-nuclear magnetic resonance spectroscopy |
| Q46513700 | Characterization and evaluation of human embryonic stem cells |
| Q28085565 | Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies |
| Q42114429 | Chondrocytes derived from mouse embryonic stem cells |
| Q39865302 | Chondrogenesis of synovium-derived mesenchymal stem cells in photopolymerizing hydrogel scaffolds |
| Q82747561 | Class-, gene-, and group-specific HLA silencing by lentiviral shRNA delivery |
| Q33812310 | Clinical potentials of human pluripotent stem cells in lung diseases |
| Q53437328 | Co-culture of mesenchymal-like stromal cells derived from human foreskin permits long term propagation and differentiation of human embryonic stem cells. |
| Q37142739 | Combinatorial and rational approaches to polymer synthesis for medicine |
| Q90353077 | Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws |
| Q53434353 | Comparative analysis of telomere length, telomerase and reverse transcriptase activity in human dental stem cells. |
| Q37074199 | Comparative characterization of mesenchymal stem cells from eGFP transgenic and non-transgenic mice |
| Q41785173 | Comparison of Differentiation of Induced Pluripotent Stem Cells and Bone-Marrow Mesenchymal Stem Cells to Osteoblast: Osteogenesis versus Pluripotency |
| Q34689577 | Comparison of odontogenic differentiation of human dental follicle cells and human dental papilla cells |
| Q42136709 | Comparison of the depolarization response of human mesenchymal stem cells from different donors |
| Q36909143 | Concepts for the clinical use of stem cells in equine medicine |
| Q34347602 | Concise review: a high-content screening approach to stem cell research and drug discovery |
| Q48481283 | Confined 3D microenvironment regulates early differentiation in human pluripotent stem cells |
| Q61703384 | Continuous hypoxic culturing maintains activation of Notch and allows long-term propagation of human embryonic stem cells without spontaneous differentiation |
| Q36722039 | Creation of a biological pacemaker by gene- or cell-based approaches |
| Q52011876 | Critical roles of Src family tyrosine kinases in excitatory neuronal differentiation of cultured embryonic stem cells. |
| Q24646497 | Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine |
| Q47604078 | Current science of regenerative medicine with stem cells |
| Q60912794 | DeepNEU: cellular reprogramming comes of age - a machine learning platform with application to rare diseases research |
| Q34595854 | Defined culture conditions of human embryonic stem cells |
| Q37844151 | Defining pluripotent stem cells through quantitative proteomic analysis. |
| Q34038983 | Derivation and long-term culture of human parthenogenetic embryonic stem cells using human foreskin feeders |
| Q39658013 | Derivation, characterization, and gene expression profile of two new human ES cell lines from India |
| Q36299248 | Designer blood: creating hematopoietic lineages from embryonic stem cells. |
| Q46124101 | Detecting clustering and ordering binding patterns among transcription factors via point process models |
| Q36151629 | Detection and characterization of hepatic engraftment of embryonic stem derived cells by fluorescent stereomicroscopy |
| Q90952575 | Developing Cell-Based Therapies for RPE-Associated Degenerative Eye Diseases |
| Q45345133 | Differences between human and mouse embryonic stem cells |
| Q40439270 | Differentiation of embryonic stem cells after transplantation into peritoneal cavity of irradiated mice and expression of specific germ cell genes in pluripotent cells. |
| Q38168212 | Differentiation of hESCs into Mesodermal Subtypes: Vascular-, Hematopoietic- and Mesenchymal-lineage Cells. |
| Q33305672 | Differentiation of human embryonic stem cells on periodontal ligament fibroblasts in vitro |
| Q36689690 | Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds |
| Q33332156 | Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions |
| Q46560967 | Differentiation of murine embryonic stem cells in skeletal muscles of mice |
| Q34565279 | Directed differentiation of embryonic stem cells: genetic and epigenetic methods |
| Q35036684 | Directed mouse embryonic stem cells into leydig-like cells rescue testosterone-deficient male rats in vivo |
| Q36911189 | Directing human embryonic stem cells to generate vascular progenitor cells |
| Q28650516 | Disease modeling using human induced pluripotent stem cells: lessons from the liver |
| Q35893653 | Donor bone marrow transplantation: chimerism and tolerance |
| Q37591306 | ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective |
| Q34091050 | Early events in xenograft development from the human embryonic stem cell line HS181--resemblance with an initial multiple epiblast formation |
| Q28534979 | Effect of antibiotics against Mycoplasma sp. on human embryonic stem cells undifferentiated status, pluripotency, cell viability and growth |
| Q39166334 | Effects of 3D microwell culture on growth kinetics and metabolism of human embryonic stem cells |
| Q41875552 | Effects of 3D microwell culture on initial fate specification in human embryonic stem cells. |
| Q35614119 | Effects of bone marrow cell transplant on thyroid function in an I131-induced low T4 and elevated TSH rat model |
| Q46516496 | Effects of cryopreservation on the transcriptome of human embryonic stem cells after thawing and culturing |
| Q34226369 | Effects of group culture on the development of discarded human embryos and the construction of human embryonic stem cell lines |
| Q40135911 | Efficient Gene Knockdowns in Mouse Embryonic Stem Cells Using MicroRNA-Based shRNAs |
| Q39734853 | Efficient derivation of Chinese human embryonic stem cell lines from frozen embryos |
| Q46797299 | Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells |
| Q37303443 | Efficient long-term cryopreservation of pluripotent stem cells at -80 °C. |
| Q58277806 | Embryoid bodies formation from chicken primordial germ cells |
| Q33883018 | Embryonic Stem Cell Conditioned Medium Supports In Vitro Maturation of Mouse Oocytes |
| Q36012093 | Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease |
| Q34736814 | Embryonic stem cells |
| Q36346482 | Embryonic stem cells and cardiomyocyte differentiation: phenotypic and molecular analyses. |
| Q51383633 | Embryonic stem cells and tissue engineering: delivering stem cells to the clinic. |
| Q42471300 | Embryonic stem cells generate airway epithelial tissue |
| Q48821859 | Embryonic stem cells generated by nuclear transfer of human somatic nuclei into rabbit oocytes |
| Q35985538 | Embryonic stem cells: a promising tool for cell replacement therapy. |
| Q34048189 | Endothelial cells derived from human embryonic stem cells |
| Q40311493 | Endothelial progenitor cells: from bench to bedside |
| Q55019699 | Engineering a microcirculation for perfusion control of ex vivo-assembled organ systems: Challenges and opportunities. |
| Q34429005 | Engineering efficient retinal pigment epithelium differentiation from human pluripotent stem cells |
| Q24677311 | Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium |
| Q43522100 | Enhanced cardiomyogenic lineage differentiation of adult bone-marrow-derived stem cells grown on cardiogel |
| Q34992287 | Epigenetic states and expression of imprinted genes in human embryonic stem cells |
| Q39843999 | Epithelial cells derived from human embryonic stem cells display p16INK4A senescence, hypermotility, and differentiation properties shared by many P63+ somatic cell types |
| Q40524318 | Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition |
| Q35537370 | Ethical issues in molecular medicine of relevance to surgeons. |
| Q39882671 | Expression of transcription factor Oct4 in bladder cancer cell line T24 and its effects on the biological characteristics of the cells |
| Q47648708 | Extracellular NME proteins: a player or a bystander? |
| Q34537156 | Fifty ways to make a neuron: shifts in stem cell hierarchy and their implications for neuropathology and CNS repair |
| Q33690530 | From c-Photina® Mouse Embryonic Stem Cells to High-Throughput Screening of Differentiated Neural Cells via an Intermediate Step Enriched in Neural Precursor Cells |
| Q38288226 | From regenerative dentistry to regenerative medicine: progress, challenges, and potential applications of oral stem cells. |
| Q83927595 | From stem cells to tissue-specific differentiation |
| Q34655798 | From teratocarcinomas to embryonic stem cells |
| Q82811520 | From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research |
| Q40625453 | Functional endothelial cells derived from rhesus monkey embryonic stem cells |
| Q77486976 | Funding embryonic stem-cell research: will commerce counteract collaboration? |
| Q37204529 | Gene and stem cell therapy in peripheral arterial occlusive disease |
| Q33313877 | Gene expression profile of neuronal progenitor cells derived from hESCs: activation of chromosome 11p15.5 and comparison to human dopaminergic neurons. |
| Q40164544 | Gene regulation networks related to neural differentiation of hESC. |
| Q37740413 | Generation of hematopoietic stem cells from human embryonic stem cells using a defined, stepwise, serum-free, and serum replacement-free monolayer culture method |
| Q37414027 | Generation of mesenchymal stromal cells from HOXB4-expressing human embryonic stem cells |
| Q40309548 | Generation of new human embryonic stem cell lines with diploid and triploid karyotypes |
| Q43218046 | Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation |
| Q37357273 | Genetically engineered mesenchymal stem cells: applications in spine therapy |
| Q35291286 | HIF-2α regulates NANOG expression in human embryonic stem cells following hypoxia and reoxygenation through the interaction with an Oct-Sox cis regulatory element |
| Q40657047 | HNF-6-independent differentiation of mouse embryonic stem cells into insulin-producing cells |
| Q92688331 | Harnessing the mesenchymal stem cell secretome for regenerative urology |
| Q51625673 | Heart valve tissue engineering -- where do we stand? |
| Q33722594 | Highly Efficient Neural Conversion of Human Pluripotent Stem Cells in Adherent and Animal-Free Conditions |
| Q37878875 | Histone acetylation and its role in embryonic stem cell differentiation |
| Q34659115 | Human ES cells--haematopoiesis and transplantation strategies |
| Q52308673 | Human Embryonic Stem Cell Derived from Early Stage Fertilized Ovum: Non Immunogenic and Universal, Neuronal and Non-neuronal Cell Lines. |
| Q34023774 | Human Embryonic Stem Cells Undergo Osteogenic Differentiation in Human Bone Marrow Stromal Cell Microenvironments |
| Q36093158 | Human amniotic fluid stem cell preconditioning improves their regenerative potential |
| Q38541319 | Human dental pulp stem cells: Applications in future regenerative medicine |
| Q40434564 | Human embryoid body-derived stem cells in co-culture with bladder smooth muscle and urothelium |
| Q36804578 | Human embryonic stem cell-derived cardiomyocytes: inducing strategies. |
| Q84348270 | Human embryonic stem cells (hESCs) cultured under distinctive feeder-free culture conditions display global gene expression patterns similar to hESCs from feeder-dependent culture conditions |
| Q37023827 | Human embryonic stem cells and cardiac repair |
| Q41822569 | Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis |
| Q36672098 | Human embryonic stem cells: an in vitro model to study mechanisms controlling pluripotency in early mammalian development |
| Q42357402 | Human embryonic stem cells: living on the edge |
| Q36498790 | Human embryonic stem cells: preclinical perspectives |
| Q39771788 | Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study |
| Q33788845 | Human stem cells for craniomaxillofacial reconstruction. |
| Q36936242 | Hydrophobic surfaces for enhanced differentiation of embryonic stem cell-derived embryoid bodies |
| Q37490580 | Identification of a distinct small cell population from human bone marrow reveals its multipotency in vivo and in vitro |
| Q35296675 | Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells |
| Q50704624 | Identification of small signalling molecules promoting cardiac-specific differentiation of mouse embryonic stem cells. |
| Q33913550 | Identification of specific pluripotent stem cell death--inducing small molecules by chemical screening. |
| Q36737033 | Immune response to stem cells and strategies to induce tolerance |
| Q47434444 | Immunoexpression of PPAR-γ and osteocalcin proteins for bone repair of critical-size defects treated with fragmented autogenous abdominal adipose tissue graft |
| Q34774684 | Immunological barriers to stem-cell based cardiac repair |
| Q37492419 | In Vitro Osteogenic Potential of Green Fluorescent Protein Labelled Human Embryonic Stem Cell-Derived Osteoprogenitors. |
| Q40596298 | In vitro characterization of genetically modified embryonic stem cells as a therapy for murine mucopolysaccharidosis type IIIA. |
| Q37341327 | In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. |
| Q26996540 | Induced pluripotent stem cell (iPSCs) and their application in immunotherapy |
| Q52430407 | Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal. |
| Q29144285 | Induction of insulin production in rat pancreatic acinar carcinoma cells by conophylline |
| Q58133820 | Inhibition of cell growth by cellular differentiation into adipocyte-like cells in dexamethasone sensitive cancer cell lines |
| Q51430101 | Inhibition of human embryonic stem cell differentiation by mechanical strain. |
| Q35154388 | Integrating omics into the cardiac differentiation of human pluripotent stem cells |
| Q26269943 | Integrative genomic and functional analyses reveal neuronal subtype differentiation bias in human embryonic stem cell lines |
| Q38342080 | Intranasal delivery of stem cells as therapy for central nervous system disease |
| Q41787137 | Isolation and therapeutic potential of human haemopoietic stem cells |
| Q58702047 | Isolation, Culture, and Functional Characterization of Human Embryonic Stem Cells: Current Trends and Challenges |
| Q90694143 | KHDC3L mutation causes recurrent pregnancy loss by inducing genomic instability of human early embryonic cells |
| Q41015974 | Lineage-specific Expression of miR-200 Family in Human Embryonic Stem Cells during In Vitro Differentiation |
| Q33932268 | Low O2 tensions and the prevention of differentiation of hES cells |
| Q34903281 | Low immunogenicity of neural progenitor cells differentiated from induced pluripotent stem cells derived from less immunogenic somatic cells |
| Q35983860 | Lower Oncogenic Potential of Human Mesenchymal Stem Cells Derived from Cord Blood Compared to Induced Pluripotent Stem Cells. |
| Q26770098 | Lung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic Approaches |
| Q35928433 | Lung stem and progenitor cells |
| Q38179665 | Lung stem and progenitor cells in tissue homeostasis and disease |
| Q59790767 | MEIS2 regulates endothelial to hematopoietic transition of human embryonic stem cells by targeting TAL1 |
| Q21562511 | MUC1* mediates the growth of human pluripotent stem cells |
| Q36334388 | Macrophage differentiation from embryoid bodies derived from human embryonic stem cells |
| Q36426321 | Mammalian stem cells |
| Q39444582 | Meniscus induced self organization of multiple deep concave wells in a microchannel for embryoid bodies generation |
| Q34294935 | Mesenchymal stem cell therapy and acute graft-versus-host disease: a review |
| Q37068904 | Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application |
| Q38849276 | Mining the topography and dynamics of the 4D Nucleome to identify novel CNS drug pathways |
| Q40431743 | Modulation of Wnt/β-catenin signaling in human embryonic stem cells using a 3-D microwell array. |
| Q33854168 | Molecular ties between the cell cycle and differentiation in embryonic stem cells |
| Q36667441 | Multipotent adult progenitor cell and stem cell plasticity |
| Q37240998 | Nanotechnology for regenerative medicine: nanomaterials for stem cell imaging |
| Q43617676 | Neural stem cell therapies for enteric nervous system disorders |
| Q39174655 | Novel therapeutics for Stargardt disease |
| Q33675089 | Oct-4 controls cell-cycle progression of embryonic stem cells |
| Q40068733 | Oct-4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress: effects associated with Stat3/survivin |
| Q35749938 | Origins of mammalian hematopoiesis: in vivo paradigms and in vitro models |
| Q46462488 | Ovarian follicular development stimulated by leuprorelin acetate plus human menopausal gonadotropin in chimpanzees |
| Q36891566 | Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome |
| Q37765396 | Pancreatic beta-cell signaling: toward better understanding of diabetes and its treatment |
| Q29617959 | Pluripotency of mesenchymal stem cells derived from adult marrow |
| Q36255019 | Pluripotent stem cell applications for regenerative medicine |
| Q37584979 | Pluripotent stem cell studies elucidate the underlying mechanisms of early embryonic development |
| Q35605784 | Potential of embryonic and adult stem cells in vitro. |
| Q37824305 | Potential of human embryonic stem cells in cartilage tissue engineering and regenerative medicine. |
| Q26866266 | Preclinical stem cell therapy in Chagas Disease: Perspectives for future research |
| Q40611030 | Preimplantation genetic diagnosis as a novel source of embryos for stem cell research |
| Q35101952 | Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen |
| Q42725916 | Promoted differentiation of cynomolgus monkey ES cells into hepatocyte-like cells by co-culture with mouse fetal liver-derived cells |
| Q73755886 | Prospects for regeneration of gastrointestinal epithelia using bone-marrow cells |
| Q73120665 | R162W mutation of keratin 9 in a family with autosomal dominant palmoplantar keratoderma with unique histologic features |
| Q33941314 | RNA: state memory and mediator of cellular phenotype |
| Q34109426 | ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium |
| Q91950181 | Rapid translocation of pluripotency-related transcription factors by external uniaxial forces |
| Q34731253 | Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells |
| Q28081801 | Reforming craniofacial orthodontics via stem cells |
| Q22251075 | Regenerating the heart |
| Q38022026 | Regenerative therapy for retinal disorders. |
| Q35005781 | Regulation of PTEN/Akt pathway enhances cardiomyogenesis and attenuates adverse left ventricular remodeling following thymosin β4 Overexpressing embryonic stem cell transplantation in the infarcted heart |
| Q38280712 | Reprogramming by lineage specifiers: blurring the lines between pluripotency and differentiation |
| Q33641396 | Rescue of developmental defects by blastocyst stem cell injection: towards elucidation of neomorphic corrective pathways |
| Q36959537 | Review article: stem cells in human reproduction |
| Q35064623 | SIRT1 Deficiency Downregulates PTEN/JNK/FOXO1 Pathway to Block Reactive Oxygen Species-Induced Apoptosis in Mouse Embryonic Stem Cells |
| Q64111423 | Self-Assembling Peptides as Extracellular Matrix Mimics to Influence Stem Cell's Fate |
| Q38216498 | Self-renewal and cell lineage differentiation strategies in human embryonic stem cells and induced pluripotent stem cells. |
| Q33833613 | Small molecules and stem cells. Potency and lineage commitment: the new quest for the fountain of youth |
| Q35076609 | Small molecules for cell reprogramming and heart repair: progress and perspective |
| Q50085975 | Specific Cell (Re-)Programming: Approaches and Perspectives |
| Q35125820 | Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. |
| Q38540260 | Stem Cells for Temporomandibular Joint Repair and Regeneration |
| Q50021446 | Stem Cells for Urinary Incontinence: Functional Differentiation or Cytokine Effects? |
| Q38029828 | Stem cell and biomaterials research in dental tissue engineering and regeneration |
| Q37143890 | Stem cell and regenerative science applications in the development of bioengineering of renal tissue |
| Q34988364 | Stem cell medicine encounters the immune system |
| Q36883565 | Stem cell research and clinical development in tendon repair |
| Q37544884 | Stem cell therapy for cardiac repair: benefits and barriers |
| Q26865849 | Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications |
| Q37665063 | Stem cell-mediated neovascularization in heart repair |
| Q36228883 | Stem cells |
| Q57635832 | Stem cells and cardiovascular tissue repair: Mechanism, methods, and clinical applications |
| Q35629581 | Stem cells as vehicles for orthopedic gene therapy |
| Q34655280 | Stem cells for obstetricians and gynecologists |
| Q34552765 | Stem cells in clinical practice: applications and warnings |
| Q34626511 | Stem cells in the adult pancreas and liver |
| Q34679324 | Stem cells on the way to restorative medicine |
| Q35978577 | Stem cells today: B1. Bone marrow stem cells |
| Q36254634 | Stem cells: From embryology to cellular therapy? An appraisal of the present state of art. |
| Q37854452 | Stem cells: The therapeutic role in the treatment of diabetes mellitus |
| Q36304941 | Stem cells: classifications, controversies, and clinical applications |
| Q31039213 | Stem cells: hype or hope? |
| Q37085785 | Stem cells: potential therapeutics for periodontal regeneration. |
| Q36521024 | Stem cells: potential therapy for age-related diseases. |
| Q34778010 | Stem cells: sources and applications. |
| Q38536543 | Synthetic Extracellular Microenvironment for Modulating Stem Cell Behaviors. |
| Q39044593 | Synthetic niches for differentiation of human embryonic stem cells bypassing embryoid body formation |
| Q36632068 | TGFbeta/Activin/Nodal pathway in inhibition of human embryonic stem cell differentiation by mechanical strain |
| Q58047155 | Tau EGFP embryonic stem cells: An efficient tool for neuronal lineage selection and transplantation |
| Q40345692 | Temporal and parental-specific expression of imprinted genes in a newly derived Chinese human embryonic stem cell line and embryoid bodies |
| Q42282173 | Tensile forces applied on a cell-embedded three-dimensional scaffold can direct early differentiation of embryonic stem cells toward the mesoderm germ layer |
| Q53281892 | The Human Embryoid Body Cystic Core Exhibits Architectural Complexity Revealed by use of High Throughput Polymer Microarrays. |
| Q36808786 | The Korean research & development program on micro-electro-mechanical systems (MEMS) in medical applications |
| Q39386163 | The Nexus of Stem Cell-Derived Beta-Cells and Genome Engineering |
| Q33294319 | The development of high-throughput screening approaches for stem cell engineering |
| Q42813285 | The effect of human embryonic stem cells (hESCs) long-term normoxic and hypoxic cultures on the maintenance of pluripotency |
| Q41680262 | The effects of silver nanoparticles on mouse embryonic stem cell self-renewal and proliferation |
| Q84624083 | The expansion of human ES and iPS cells on porous membranes and proliferating human adipose-derived feeder cells |
| Q35969352 | The genetic and epigenetic journey of embryonic stem cells into mature neural cells. |
| Q37310625 | The immune boundaries for stem cell based therapies: problems and prospective solutions. |
| Q39769604 | The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells |
| Q36974665 | The pharmacology of regenerative medicine |
| Q36390804 | The potential of stem cell therapies for neurological diseases |
| Q46733782 | The reprogramming factor nuclear receptor subfamily 5, group A, member 2 cannot replace octamer-binding transcription factor 4 function in the self-renewal of embryonic stem cells |
| Q58924840 | The swinging pendulum of cancer immunotherapy personalization |
| Q33811629 | The therapeutic potential of stem cells from adults |
| Q37323527 | The use of gating technology in bioengineering insulin-secreting cells from embryonic stem cells |
| Q42206146 | The use of hTERT-immortalized cells in tissue engineering |
| Q39185427 | The use of human amniotic fluid mesenchymal stem cells as the feeder layer to establish human embryonic stem cell lines |
| Q35882655 | Therapeutic potential of lung epithelial progenitor cells derived from embryonic and induced pluripotent stem cells |
| Q33366796 | Thrombopoietin regulates differentiation of rhesus monkey embryonic stem cells to hematopoietic cells |
| Q24799127 | Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerate |
| Q37718033 | Tissue engineering and regenerative medicine research perspectives for pediatric surgery |
| Q37806958 | Tissue-Derived Stem and Progenitor Cells |
| Q41894791 | Toll-like receptor 2 mediates proliferation, survival, NF-kappaB translocation, and cytokine mRNA expression in LIF-maintained mouse embryonic stem cells |
| Q37398305 | Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. |
| Q51817479 | Transcriptional expression profile of cultured human embryonic stem cells in vitro and in vivo. |
| Q50000183 | Transcriptome variations among human embryonic stem cell lines are associated with their differentiation propensity |
| Q33731203 | Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice |
| Q35781214 | Treatment for end-stage renal disease: an organogenesis/tissue engineering odyssey |
| Q101237390 | Visualization and quantification of dynamic intercellular coupling in human embryonic stem cells using single cell sonoporation |
| Q41983578 | Wharton's jelly stem cells: a novel cell source for oral mucosa and skin epithelia regeneration. |
Search more.